CGN.F - Cigna Corporation

Frankfurt - Frankfurt Delayed Price. Currency in EUR
158.76
-1.22 (-0.76%)
At close: 4:50PM CEST
Stock chart is not supported by your current browser
Previous Close159.98
Open158.26
Bid156.90 x 20000
Ask157.30 x 20000
Day's Range158.26 - 158.76
52 Week Range128.22 - 200.25
Volume18
Avg. Volume5
Market Cap36.158B
Beta (3Y Monthly)N/A
PE Ratio (TTM)14.20
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Morningstar4 months ago

    Fresh Look at Managed Care Results in Moat Upgrades

    To  CVS Health CVS and Cigna we now assign positive trend ratings, largely attributable to the competitive benefits we expect these businesses to achieve through their integrations of Aetna and Express Scripts, respectively. Unrivaled scale allows UnitedHealth to price its insurance book commensurate with the lowest cost per insured member of the companies we cover, which has led to industry-leading gains in membership over the past five years.

  • Larry Robbins Plunges Into Dan Loeb's Cigna, Buys 3 in 4th Quarter
    GuruFocus.com5 months ago

    Larry Robbins Plunges Into Dan Loeb's Cigna, Buys 3 in 4th Quarter

    Top buys include Third Point manager’s top holding Baxter

  • Jeff Auxier Establishes 4 New Holdings in 4th Quarter
    GuruFocus.com5 months ago

    Jeff Auxier Establishes 4 New Holdings in 4th Quarter

    Top buy is Daniel Loeb’s Cigna

  • Brandes Investments' Top 5 Buys in 4th Quarter
    GuruFocus.com5 months ago

    Brandes Investments' Top 5 Buys in 4th Quarter

    Top buys include Loeb’s new holding Cigna

  • Dan Loeb Buys Cigna and Sells Alibaba, Microsoft, Netflix
    GuruFocus.com5 months ago

    Dan Loeb Buys Cigna and Sells Alibaba, Microsoft, Netflix

    Third Point manager drops 10 positions in tough fourth quarter

  • Lightning Strikes the Least Popular Middlemen in Healthcare
    Motley Fool5 months ago

    Lightning Strikes the Least Popular Middlemen in Healthcare

    The Trump administration's trying to throw a wrench into America's complex reimbursement system for expensive drugs.

  • Cigna Corp (CI) Q4 2018 Earnings Conference Call Transcript
    Motley Fool5 months ago

    Cigna Corp (CI) Q4 2018 Earnings Conference Call Transcript

    CI earnings call for the period ending December 31, 2018.

  • TheStreet.com5 months ago

    Cigna Shares Fall Despite Strong Earnings

    Cigna reports quarterly earnings above forecasts but full-year guidance below analysts' expectations.

  • CNBC5 months ago

    Cigna sinks on investor worries about Trump drug rebate rule change

    Cigna CEO David Cordani doesn't see the Trump administration's new proposal to cut Medicare pharmacy benefit rebates as a threat to its growth, as it embarks on integrating its newly acquired PBM firm Express Scripts.

  • Reuters5 months ago

    Cigna CEO shrugs off concerns about proposed change to rebate rules

    The U.S. government's proposal to eliminate rebates that pharmacy benefit managers receive from drugmakers will not have a meaningful impact on growth, and does not affect the commercial market, Cigna Corp Chief Executive Officer David Cordani said on Friday. Investors are worried that Cigna, which closed its $52 billion acquisition of PBM Express Scripts in December, could be hurt by the Trump administration's proposal targeting after-market discounts that middlemen in the pharmaceutical supply chain have received for decades.

  • Reuters5 months ago

    Cigna says no meaningful impact on growth from rebates rule

    "The proposed rebate rule will not have a meaningful impact on our growth or earnings trajectory," Cordani said on a conference call with analysts. The U.S. government on Thursday proposed a rule to end a decades-old system of after-market discounts called rebates that pharmacy benefit managers receive from drugmakers, a potential blow to companies like Cigna's Express Scripts, which act as middlemen in the pharmaceuticals supply chain.

  • CNBC5 months ago

    Stocks making the biggest moves premarket: Amazon, Merck, Cigna, Honeywell & more

    Check out the companies making headlines before the bell: Merck MRK – Merck earned an adjusted $1.04 per share for the fourth quarter, beating estimates by a penny a share. Revenue came in very slightly above Wall Street forecasts.

  • Associated Press5 months ago

    Cigna: 4Q Earnings Snapshot

    The Bloomfield, Connecticut-based company said it had profit of 55 cents per share. Earnings, adjusted for non-recurring costs, came to $2.46 per share. The results missed Wall Street expectations. The ...

  • Reuters5 months ago

    Cigna fourth-quarter revenue rises 34.5 percent

    Cigna Corp reported a 34.5 percent rise in quarterly revenue, helped by higher enrollment in the first quarter since it closed its acquisition of pharmacy benefits manager Express Scripts. Cigna's net ...

  • CNBC6 months ago

    Trump administration proposes rules for Medicare plans as it seeks to lower drug prices

    The Trump administration's new proposals would ban what it calls "backdoor rebates," as it seeks to lower drug costs for consumers at the pharmacy counter. The administration says those confidential rebates have led to a "perverse incentive" for drug makers to make list prices on drugs artificially high. HHS Secretary Alex Azar says in a statement that the goal would be to create a system that prioritizes savings for patients.

  • TheStreet.com6 months ago

    Friday Earnings Preview: Cigna, Merck, Exxon, Honeywell All Report

    After strong earnings from aircraft manufacturing behemoth Boeing Co. propelled the U.S. market higher Wednesday, stocks were mixed Thursday. The Dow Jones Industrial Average fell more than 50 points Thursday afternoon, giving back some of its gains Wednesday.

  • Benzinga6 months ago

    Cigna Q4 Earnings Preview

    Cigna (NYSE: CI ) unveils its next round of earnings this Friday, Feb. 1. Get prepared with Benzinga's ultimate preview for Cigna's Q4 earnings. Earnings and Revenue Analysts predict Cigna will report ...

  • Anthem Stock Hits Buy Point Intraday On Strong Outlook, Earnings
    Investor's Business Daily6 months ago

    Anthem Stock Hits Buy Point Intraday On Strong Outlook, Earnings

    Anthem stock vaulted higher, touching a buy point intraday, after the company issued a far-better-than-expected profit forecast this year.

  • Cigna forecasts slow revenue growth for 2019
    Yahoo Finance Video5 months ago

    Cigna forecasts slow revenue growth for 2019

    Cigna's stock down after forecasting full year revenue below analysts' expectations. The company also facing the possibility of of the U.S. government ending rebates that it says are to blame for high drug prices. Yahoo Finance's Jackie DeAngelis and Brian Cheung discuss.